CTEV logo

Claritev Corporation Stock Price

NYSE:CTEV Community·US$778.7m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

CTEV Share Price Performance

US$47.12
39.82 (545.48%)
US$55.00
Fair Value
US$47.12
39.82 (545.48%)
14.3% undervalued intrinsic discount
US$55.00
Fair Value
Price US$47.12
AnalystLowTarget US$55.00
AnalystConsensusTarget US$80.00
AnalystHighTarget US$86.00

CTEV Community Narratives

AnalystLowTarget·
Fair Value US$55 14.3% undervalued intrinsic discount

Rising Regulation And Cost Burdens Will Strain US Healthcare Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$80 41.1% undervalued intrinsic discount

Analysts Boost Claritev Valuation Amid Growth Optimism and Strategic Developments

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystHighTarget·
Fair Value US$86 45.2% undervalued intrinsic discount

Aging Global Population And Digital Health Will Transform Diagnostics

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$86
45.2% undervalued intrinsic discount
Revenue growth
3.65% p.a.
Profit Margin
13.12%
Future PE
15.15x
Share price in 2028
US$118.92

Updated Narratives

CTEV logo

Analysts Boost Claritev Valuation Amid Growth Optimism and Strategic Developments

Fair Value: US$80 41.1% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CTEV logo

Rising Regulation And Cost Burdens Will Strain US Healthcare Margins

Fair Value: US$55 14.3% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CTEV logo

Aging Global Population And Digital Health Will Transform Diagnostics

Fair Value: US$86 45.2% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Fair value with low risk.

3 Risks
1 Reward

Claritev Corporation Key Details

US$951.0m

Revenue

US$240.5m

Cost of Revenue

US$710.6m

Gross Profit

US$1.1b

Other Expenses

-US$341.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-20.68
74.72%
-35.93%
-4,554.7%
View Full Analysis

About CTEV

Founded
1980
Employees
2700
CEO
Travis Dalton
WebsiteView website
www.claritev.com

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.

Recent CTEV News & Updates

Recent updates

No updates